Use of a Telehomecare Program for Young Patients With New Onset Type 1 Diabetes

Huot, Celine, M.D.

Status: Completed

Conditions: Diabetes Mellitus, Type 1

Treatments: Device: Telehomecare (Intelligent Distance Patient Monitoring); Other: Standard education and follow up at diabetes clinic

Study type: Interventional

Funder types: Other

Identifiers

NCT01401790

CHUSTEJUSTINE2644

Details and patient eligibility

About

In a Pediatric University Teaching Hospital in Montreal, an Intelligent Distance Patient Monitoring Program was developed to allow for:

• Automatic download of blood glucose levels
• Automatic alerts indicating hypoglycemias, hyperglycemias and ketones to the medical team
• Changes in treatment plan by the diabetes professionals
• E mail exchanges between families and health care professionals
• Reinforcement of teaching program

Use of this program does not replace the existing diabetes education program nor does it preclude contacts with the diabetes team. This service was devised to complement the care already in place for families of children and adolescents with diabetes, hence the term ''telehomecare-enhanced'' approach.

Hypotheses

• This approach would not incur more health problems for Web e Phone users when compared to patients treated by the ''conventional'' approach (telephone and FAX).
• Use of the Web e Phone would save time for members of the diabetes health providers and consequently cut costs.
• This means of communication would be acceptable and user friendly for both families and health care professionals.

OBJECTIVE - To determine the effects of a telehomecare (THC) program used for 3 months in families of children and adolescents with newly diagnosed type 1 diabetes.

RESEARCH DESIGN AND METHODS - A bilingual telehomecare program was developed for type 1 diabetes at the Centre Hospitalier Universitaire Sainte-Justine in Montreal. Between February 2008 and August 2009, newly diagnosed patients and their family were randomly assigned to the standard education program or to the telehomecare-enhanced group. Outcomes of interest were patients' and parents' health (reported number for total and nocturnal hypoglycemias; quality of life using the Diabetes Quality of life for Youth questionnaire and a validated Life Habits survey); knowledge of diabetes (using pre and post intervention questionnaires); organizational impacts (number and time for contacts with the nurses or with the physician on call) and family satisfaction with the software application.

Full description

STUDY PROTOCOL

This is a randomized controlled study, unblinded.

The recruitment occured on Day 3 of teaching: random assignment (1:1) to receive either traditional follow up (telephone contacts and FAX communications) with the designated nurse OR a follow up with telehomecare PLUS the follow up by a specialized nurse.

If the patient is designated to telehomecare, the training is provided on day of recruitment and patient leaves with the Web e Phone. Activation of the device must be done at home to enable for transmission of information.

Families complete questionnaires to evaluate knowledge, Quality of Life Questionnaires (Skinner modified), a validated Life Habits survey and a satisfaction questionnaire at recruitment (time 0) and at study completion (3 months) (Children must be aged more than 8 years).

All reported hypoglycemias (less than 3 mmol/L) and nocturnal hypoglycemias by any means (telephone, FAX or Web e Phone) during the follow up period (suggested for 3 months) are to be accounted for.

Enrollment: 86 patients

Sex: All

Ages: 6 months to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Child or adolescent with newly diagnosed type 1 diabetes

Exclusion criteria

• Inability to write or communicate in writing in French or English Blindness Exclusive follow up in another health center once teaching is complete

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

86 participants in 2 patient groups

Telehomecare

Experimental group

Description:

3 month use of a new telehomecare program

Treatment:

Device: Telehomecare (Intelligent Distance Patient Monitoring)

Control

Active Comparator group

Description:

3 month regular education program and follow up at the Diabetes Clinic

Treatment:

Other: Standard education and follow up at diabetes clinic